Home » Newsletters » BioWorld Science

BioWorld Science

June 17, 2004

View Archived Issues

Antitumor effects of CpG-7909 in several types of human cancer

Synthetic Australian snake venom derivative effective for wound healing

Restoration of CFTR function with SV40 gene therapy

Antitumor effects and safety of rhLF in advanced cancer patients

Novel potent and selective 5-HT2C agonists for the treatment of obesity discovered at Wyeth

Study results on GLP-1 analogue CJC-1131 presented during ADA

Synergistic effects of IL-21 and rituximab in B-lymphoma cell lines

An EGF vaccine reported to improve survival in advanced lung cancer

Positive preliminary phase III results for Sativex in neuropathic pain

Crucell enters PER.C6 licensing agreement with Chiron

FDA accepts IND for stem cell mobilizing drug CTCE-0214

Sosei's phase I trial of SOU-001 cleared to begin in U.K.

First patient enrolled in phase I/II study of TheraCIM hR3 for pediatric glioma

ZYC-101a shows 100% efficacy in patients with high-grade cervical dysplasia

Pivotal phase III trial of Rencarex for renal cell carcinoma opens enrollment

Symadex enters phase I in patients with advanced solid tumors

SVT-40776 progresses into phase II for urinary incontinence

Daily Infergen plus ribavirin evaluated for HCV in new DIRECT trial

Ovation acquires Buronil from Lundbeck

IR-103 enters first clinical study for HIV

First phase IIa patients receive BrachySil for liver cancer

Two series of gamma-secretase inhibitors identified at Merck

AstraZeneca presents novel PTP-1B inhibitors

Boehringer Ingelheim scientists describe new ICAM-1/LFA-1 interaction inhibitors

Dual alpha7 nAChR agonists/5-HT3 antagonists for psychosis, cognition disorders, etc.

New antilipolytic agents targeting hRUP38 receptors

T-614 reported safe and effective in patients with active rheumatoid arthritis

Novel chemokine CCR1 antagonists and their use covered by Pfizer patent

New monoamine reuptake inhibitors developed at NeuroSearch

Preliminary data on the efficacy of epratuzumab in SLE

Clinical response found with eculizumab in rheumatoid arthritis

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...